Bladder Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines

被引：4

作者：

Flaig, Thomas W. ^{[1
]}

Spiess, Philippe E. ^{[2
]}

Abern, Michael ^{[3
]}

Agarwal, Neeraj ^{[4
]}

Bangs, Rick

Buyyounouski, Mark K. ^{[5
]}

Chan, Kevin ^{[6
]}

Chang, Sam S. ^{[7
]}

Chang, Paul ^{[8
]}

Friedlander, Terence ^{[9
]}

Greenberg, Richard E. ^{[10
]}

Guru, Khurshid A. ^{[11
]}

Herr, Harry W. ^{[12
]}

Hoffman-Censits, Jean ^{[13
]}

Kaimakliotis, Hristos ^{[14
]}

Kishan, Amar U. ^{[15
]}

Kundu, Shilajit ^{[16
]}

Lele, Subodh M. ^{[17
]}

Mamtani, Ronac ^{[18
]}

Mian, Omar Y. ^{[19
,20
]}

Michalski, Jeff ^{[21
,22
]}

Montgomery, Jeffrey S. ^{[23
]}

Parikh, Mamta ^{[24
]}

Patterson, Anthony ^{[25
]}

Peyton, Charles ^{[26
]}

Plimack, Elizabeth R. ^{[10
]}

Preston, Mark A. ^{[27
]}

Richards, Kyle ^{[28
]}

Sexton, Wade J. ^{[2
]}

Siefker-Radtke, Arlene O. ^{[29
]}

Stewart, Tyler ^{[30
]}

Sundi, Debasish ^{[31
,32
]}

Tollefson, Matthew ^{[33
]}

Tward, Jonathan ^{[4
]}

Wright, Jonathan L. ^{[34
]}

Cassara, Carly J. ^{[35
]}

Gurski, Lisa A. ^{[35
]}

机构：

[1] Univ Colorado, Ctr Canc, Denver, CO 80202 USA

[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[3] Duke Canc Inst, Durham, NC USA

[4] Univ Utah, Huntsman Canc Inst, Biol, Salt Lake City, UT USA

[5] Stanford Canc Inst, Stanford, CA USA

[6] City Hope Natl Med Ctr, Monrovia, CA USA

[7] Vanderbilt Ingram Canc Ctr, Vanderbilt, TN 37232 USA

[8] UChicago Med, Comprehens Canc Ctr, Maywood, IL USA

[9] UCSF, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[10] Fox Chase Canc Ctr, Oreland, PA USA

[11] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[12] Mem Sloan Kettering Canc Ctr, Commack, NY USA

[13] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[14] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN USA

[15] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA

[16] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA

[17] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[18] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA

[19] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[20] Cleveland Clin, Taussig Canc Inst, Cleveland Hts, OH USA

[21] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[22] Washington Univ, Sch Med, St Louis, MO USA

[23] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA

[24] UC Davis, Comprehens Canc Ctr, Davis, AL USA

[25] Univ Tennessee, Hlth Sci Ctr, St Jude Childrens Res Hosp, Germantown, TN USA

[26] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA

[27] Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA

[28] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA

[29] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[30] UC San, Diego Moores Canc Ctr, San Diego, CA USA

[31] Ohio State Univ, James Canc Hosp, Comprehens Canc Ctr, Columbus, OH USA

[32] Solove Res Inst, Columbus, OH USA

[33] Mayo Clin, Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL USA

[34] Fred Hutchinson Canc Ctr, Sunnyside, WA USA

[35] Natl Comprehens Canc Network, Rockledge, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2024年 / 22卷 / 04期

关键词：

BACILLUS-CALMETTE-GUERIN; MITOMYCIN-C; SINGLE-ARM; OPEN-LABEL; METAANALYSIS; PEMBROLIZUMAB; RECURRENCE; RISK; MULTICENTER; CARCINOMA;

D O I：

10.6004/jnccn.2024.0024

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Bladder cancer, the sixth most common cancer in the United States, is most commonly of the urothelial carcinoma histologic subtype. The clinical spectrum of bladder cancer is divided into 3 categories that differ in prognosis, management, and therapeutic aims: (1) non - muscle-invasive bladder cancer (NMIBC); (2) muscle invasive, nonmetastatic disease; and (3) metastatic bladder cancer. These NCCN Guidelines Insights detail recent updates to the NCCN Guidelines for Bladder Cancer, including changes in the fifth edition of the WHO Classification of Tumours: Urinary and Male Genital Tumours and how the NCCN Guidelines aligned with these updates; new and emerging treatment options for bacillus Calmette-Guerin (BCG) -unresponsive NMIBC; and updates to systemic therapy recommendations for advanced or metastatic disease.

引用

页码：216 / 225

页数：10

共 50 条

[1] Prostate Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines
Schaeffer, Edward M.
Srinivas, Sandy
Adra, Nabil
An, Yi
Bitting, Rhonda
Chapin, Brian
Cheng, Heather H.
D'Amico, Anthony Victor
Desai, Neil
Dorff, Tanya
Eastham, James A.
Farrington, Thomas A.
Gao, Xin
Gupta, Shilpa
Guzzo, Thomas
Ippolito, Joseph E.
Karnes, R. Jeffrey
Kuettel, Michael R.
Lang, Joshua M.
Lotan, Tamara
Mckay, Rana R.
Morgan, Todd
Pow-Sang, Julio M.
Reiter, Robert
Roach, Mack, III
Robin, Tyler
Rosenfeld, Stan
Shabsigh, Ahmad
Spratt, Daniel
Szmulewitz, Russell
Teply, Benjamin A.
Tward, Jonathan
Valicenti, Richard
Wong, Jessica Karen
Snedeker, Jenna
Freedman-Cass, Deborah A.
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (03): : 140 - 150
[2] Rectal Cancer, Version 3.2024 Featured Updates to the NCCN Guidelines
Benson III, Al B.
Venook, Alan P.
Adam, Mohamed
Chang, George
Chen, Yi-Jen
Ciombor, Kristen K.
Cohen, Stacey A.
Cooper, Harry S.
Deming, Dustin
Garrido-Laguna, Ignacio
Grem, Jean L.
Haste, Paul
Hecht, J. Randolph
Hoffe, Sarah
Hunt, Steven
Hussan, Hisham
Johung, Kimberly L.
Joseph, Nora
Kirilcuk, Natalie
Krishnamurthi, Smitha
Malla, Midhun
Maratt, Jennifer K.
Messersmith, Wells A.
Meyerhardt, Jeffrey
Miller, Eric D.
Mulcahy, Mary F.
Nurkin, Steven
Parikh, Aparna
Patel, Hitendra
Pedersen, Katrina
Saltz, Leonard
Schneider, Charles
Shibata, David
Shogan, Benjamin
Skibber, John M.
Sofocleous, Constantinos T.
Tavakkoli, Anna
Willett, Christopher G.
Wu, Christina
Jones, Frankie
Gurski, Lisa
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (06): : 366 - 375
[3] Systemic Mastocytosis, Version 3.2024: Featured Updates to the NCCN Guidelines
Gotlib, Jason
Gerds, Aaron T.
Abdelmessieh, Peter
Ali, Haris
Castells, Mariana
Dunbar, Andrew
Revell, Ruth Fein
George, Tracy I.
Green, Steven
Gundabolu, Krishna
Hexner, Elizabeth
Jain, Tania
Jamieson, Catriona
Kaesberg, Paul R.
Kuykendall, Andrew T.
Madanat, Yazan
Manchanda, Naveen
Masarova, Lucia
May, Jori
McMahon, Brandon
Mohan, Sanjay R.
Nadiminti, Kalyan V.
Oh, Stephen
Palmer, Jeanne
Patel, Ami
Patel, Anand A.
Podoltsev, Nikolai
Rein, Lindsay
Salit, Rachel
Talpaz, Moshe
Wadleigh, Martha
Wall, Sarah
Bergman, Mary Anne
Hochstetler, Cindy
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (2D):
[4] Bladder Cancer, Version 2.2022 Featured Updates to the NCCN Guidelines
Flaig, Thomas W.
Spiess, Philippe E.
Abern, Michael
Agarwal, Neeraj
Bangs, Rick
Boorjian, Stephen A.
Buyyounouski, Mark K.
Chan, Kevin
Chang, Sam
Friedlander, Terence
Greenberg, Richard E.
Guru, Khurshid A.
Herr, Harry W.
Hoffman-Censits, Jean
Kishan, Amar
Kundu, Shilajit
Lele, Subodh M.
Mamtani, Ronac
Margulis, Vitaly
Mian, Omar Y.
Michalski, Jeff
Montgomery, Jeffrey S.
Nandagopal, Lakshminarayanan
Pagliaro, Lance C.
Parikh, Mamta
Patterson, Anthony
Plimack, Elizabeth R.
Pohar, Kamal S.
Preston, Mark A.
Richards, Kyle
Sexton, Wade J.
Siefker-Radtke, Arlene O.
Tollefson, Matthew
Tward, Jonathan
Wright, Jonathan L.
Dwyer, Mary A.
Cassara, Carly J.
Gurski, Lisa A.
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (08): : 866 - 878
[5] NCCN Guidelines® Insights Bladder Cancer, Version 5.2018 Featured Updates to the NCCN Guidelines
Flaig, Thomas W.
Spiess, Philippe E.
Agarwal, Neeraj
Bangs, Rick
Boorjian, Stephen A.
Buyyounouski, Mark K.
Downs, Tracy M.
Efstathiou, Jason A.
Friedlander, Terence
Greenberg, Richard E.
Guru, Khurshid A.
Noah Hahn
Herr, Harry W.
Hoimes, Christopher
Inman, Brant A.
Jimbo, Masahito
Kader, A. Karim
Lele, Subodh M.
Meeks, Joshua J.
Michalski, Jeff
Montgomery, Jeffrey S.
Pagliaro, Lance C.
Pal, Sumanta K.
Patterson, Anthony
Petrylak, Daniel P.
Plimack, Elizabeth R.
Pohar, Kamal S.
Porter, Michael P.
Preston, Mark A.
Sexton, Wade J.
Siefker-Radtke, Arlene O.
Tward, Jonathan
Wile, Geoffrey
Johnson-Chilla, Alyse
Dwyer, Mary A.
Gurski, Lisa A.
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (09): : 1041 - 1053
[6] NCCN Guidelines® Insights Bladder Cancer, Version 2.2016 Featured Updates to the NCCN Guidelines
Clark, Peter E.
Spiess, Philippe E.
Agarwal, Neeraj
Bangs, Rick
Boorjian, Stephen A.
Buyyounouski, Mark K.
Efstathiou, Jason A.
Flaig, Thomas W.
Friedlander, Terence
Greenberg, Richard E.
Guru, Khurshid A.
Hahn, Noah
Herr, Harry W.
Holmes, Christopher
Inman, Brant A.
Kader, A. Karim
Kibel, Adam S.
Kuzel, Timothy M.
Lele, Subodh M.
Meeks, Joshua J.
Michalski, Jeff
Montgomery, Jeffrey S.
Pagliaro, Lance C.
Pal, Sumanta K.
Patterson, Anthony
Petrylak, Daniel
Plimack, Elizabeth R.
Pohar, Kamal S.
Porter, Michael P.
Sexton, Wade J.
Siefker-Radtke, Arlene O.
Sonpavde, Guru
Tward, Jonathan
Wile, Geoffrey
Dwyer, Mary A.
Smith, Courtney
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (10): : 1213 - 1224
[7] NCCN Guidelines® Insights Breast Cancer, Version 1.2017 Featured Updates to the NCCN Guidelines
Gradishar, William J.
Anderson, Benjamin O.
Balassanian, Ron
Blair, Sarah L.
Burstein, Harold J.
Cyr, Amy
Elias, Anthony D.
Farrar, William B.
Forero, Andres
Giordano, Sharon Hermes
Goetz, Matthew P.
Goldstein, Lori J.
Isakoff, Steven J.
Lyons, Janice
Marcom, P. Kelly
Mayer, Ingrid A.
McCormick, Beryl
Moran, Meena S.
O'Regan, Ruth M.
Patel, Sameer A.
Pierce, Lori J.
Reed, Elizabeth C.
Salerno, Kilian E.
Schwartzberg, Lee S.
Sitapati, Amy
Smith, Karen Lisa
Smith, Mary Lou
Soliman, Hatem
Somlo, George
Telli, Melinda
Ward, John H.
Shead, Dorothy A.
Kumar, Rashmi
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (04): : 433 - +
[8] NCCN Guidelines® Insights Colon Cancer, Version 2.2018 Featured Updates to the NCCN Guidelines
Benson, Al B., III
Venook, Alan P.
Al-Hawary, Mahmoud M.
Cederquist, Lynette
Chen, Yi-Jen
Ciombor, Kristen K.
Cohen, Stacey
Cooper, Harry S.
Deming, Dustin
Engstrom, Paul F.
Garrido-Laguna, Ignacio
Grem, Jean L.
Grothey, Axel
Hochster, Howard S.
Hoffe, Sarah
Hunt, Steven
Kamel, Ahmed
Kirilcuk, Natalie
Krishnamurthi, Smitha
Messersmith, Wells A.
Meyerhardt, Jeffrey
Miller, Eric D.
Mulcahy, Mary F.
Murphy, James D.
Nurkin, Steven
Saltz, Leonard
Sharma, Sunil
Shibata, David
Skibber, John M.
Sofocleous, Constantinos T.
Stoffel, Elena M.
Stotsky-Himelfarb, Eden
Willett, Christopher G.
Wuthrick, Evan
Gregory, Kristina M.
Freedman-Cass, Deborah A.
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (04): : 359 - 369
[9] NCCN Guidelines® Insights Bone Cancer, Version 2.2017 Featured Updates to the NCCN Guidelines
Biermann, J. Sybil
Chow, Warren
Reed, Damon R.
Lucas, David
Adkins, Douglas R.
Agulnik, Mark
Benjamin, Robert S.
Brigman, Brian
Budd, G. Thomas
Curry, William T.
Didwania, Aarati
Fabbri, Nicola
Hornicek, Francis J.
Kuechle, Joseph B.
Lindskog, Dieter
Mayerson, Joel
McGarry, Sean V.
Million, Lynn
Morris, Carol D.
Movva, Sujana
O'Donnell, Richard J.
Randall, R. Lor
Rose, Peter
Santana, Victor M.
Satcher, Robert L.
Schwartz, Herbert
Siegel, Herrick J.
Thornton, Katherine
Villalobos, Victor
Bergman, Mary Anne
Scavone, Jillian L.
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (02): : 155 - 167
[10] Prostate Cancer, Version 1.2016 Featured Updates to the NCCN Guidelines
Mohler, James L.
Armstrong, Andrew J.
Bahnson, Robert R.
D'Amico, Anthony Victor
Davis, Brian J.
Eastham, James A.
Enke, Charles A.
Farrington, Thomas A.
Higano, Celestia S.
Horwitz, Eric M.
Hurwitz, Michael
Kane, Christopher J.
Kawachi, Mark H.
Kuettel, Michael
Lee, Richard J.
Meeks, Joshua J.
Penson, David F.
Plimack, Elizabeth R.
Pow-Sang, Julio M.
Raben, David
Richey, Sylvia
Roach, Mack, III
Rosenfeld, Stan
Schaeffer, Edward
Skolarus, Ted A.
Small, Eric J.
Sonpavde, Guru
Srinivas, Sandy
Strope, Seth A.
Tward, Jonathan
Shead, Dorothy A.
Freedman-Cass, Deborah A.
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (01): : 19 - 30

← 1 2 3 4 5 →